TAR-0520 Gel in EGFR Inhibitor-induced Folliculitis

NCT06818058 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

EGFR Inhibitor-associated Rash

Interventions

DRUG: Brimonidine tartrate Gel
DRUG: Placebo gel (no Brimonidine tartrate)

Sponsor

Tarian Pharma